Quantitative Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Quantitative Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-48,500	Closed	-$2.59M	–	1068
2016 Q1	$2.59M	Buy	+48,500	New	+$3.58M	0.13%	200
2015 Q4	–	Sell	-17,700	Closed	-$2.08M	–	992
2015 Q3	$2.08M	Buy	+17,700	New	+$2.31M	0.16%	168
2015 Q1	–	Sell	-7,100	Closed	-$228K	–	841
2014 Q4	$228K	Buy	+7,100	New	+$213K	0.04%	398

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Quantitative Investment Management's ANAC Position: Q2 2016 in Review

Quantitative Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 48,500 shares — an estimated $2.59M sold.

Quantitative Investment Management first reported a position in ANAC in Q4 2014 and held it in 3 quarters. The position peaked at $2.59M in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Quantitative Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Quantitative Investment Management sold 48,500 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $2.59M.
Quantitative Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q4 2014 and held it in 3 quarters.
Quantitative Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $2.59M in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Quantitative Investment Management's 13F filing for Q2 2016, filed 2 Aug 2016.